SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 79.780.0%Dec 31 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (944)6/9/2005 9:53:12 AM
From: Galirayo   of 3722
 
Siemens and SEQUENOM Expand Molecular Diagnostics Working Group to Include European Collaborator Bioscientia
Thursday June 9, 6:00 am ET

SAN DIEGO, June 9 /PRNewswire-FirstCall/ -- Bioscientia, a leading international reference laboratory will participate as a European site for a joint working group on molecular diagnostics initiated by SEQUENOM, Inc. (Nasdaq: SQNM - News) and Siemens Medical Solutions of Siemens AG (NYSE: SI - News). SEQUENOM's MassARRAY® Compact System, a genetics analysis platform, will be installed at Bioscientia's clinical reference laboratory facility in Germany to benchmark the MassARRAY System in a molecular diagnostic testing environment.

[snip]
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext